Search results
'Pharma bro' Martin Shkreli accused of copying, sharing one-of-a-kind Wu-Tang Clan album
Lincoln Journal Star· 6 days agoAmerican investor Martin Shkreli faces a new lawsuit for allegedly retaining and sharing recordings...
Sun Pharma Prevails in Lipitor MDL on Class Certification, Summary Judgment | New Jersey Law Journal
Law.com· 7 days agoCounsel with Kirkland & Ellis helped Sun Pharmaceutical Industries prevail in its defense of two...
Why International Flavors (IFF) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 6 days agoThe company has introduced new business divisions — Nourish, Scent, Health & Biosciences and Pharma...
'Pharma bro' Martin Shkreli accused of copying, sharing one-of-a-kind Wu-Tang Clan album
The Post-Star· 6 days agoAmerican investor Martin Shkreli faces a new lawsuit for allegedly retaining and sharing recordings...
Gateway - Quartz
Quartz· 7 hours agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
UK’s new Netflix-style funding model for antibiotics goes live
Pharmaceutical Technology via Yahoo Finance· 4 days agoPreviously, the ...10m, GBP 15m, GBP 20m. This is a ‘fair share payment’ meant to reflect England’s’...
New Scientific Article Published on Positive Clinical Results with Painless ACD440 Against...
Digital Journal· 5 days agoSTOCKHOLM, SWEDEN / ACCESSWIRE / June 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company ...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 21 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Gateway - Quartz
Quartz· 12 hours agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 5 days agoThis would be Dupixent's seventh potential approval, Sanofi's Rowe said. So, it has the potential to...
